Raptor Pharmaceutical Corp (NASDAQ:RPTP)

8.37
Data as of Jul 25
 -0.29 / -3.35%
Today’s Change
7.12
Today|||52-Week Range
17.72
-35.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$542.7M

Company Description

Raptor Pharmaceutical Corp. is a biopharmaceutical company, which focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. It has active development programs in cystinosis, a rare genetic disease, as well as other genetic and metabolic disorders. Raptor Pharmaceutical Corp was founded on September 29, 2009 and is headquartered in Novato, CA.

Contact Information

Raptor Pharmaceutical Corp.
5 Hamilton Landing
Novato California 94949
P:(415) 408-6200
Investor Relations:

Employees

Shareholders

Other institutional32.57%
Individual stakeholders2.48%
Mutual fund holders16.76%

Top Executives

Christopher M. StarrChief Executive Officer & Director
Julie Anne SmithCEO-Designate, COO & Executive VP-Strategy
Georgia L. ErbezChief Financial Officer, Secretary & Treasurer
Patrice P. RiouxChief Medical Officer
Todd C. ZankelChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.